ESH Meeting Highlights 2005

 
 
 
‹‹‹ Click on the dates to see the daily articles!
 
 
 
 

Comments by Prof. Lars Lindholm,
President-elect of the International Society of Hypertension

ISH President-Elect Lindholm: The ISH and ESH have been sisters for many, many years. The ISH has a focus now on the developing world. There are more than 1 billion people in the world who suffer from high blood pressure and there is quite a job to undertake to promote awareness of hypertension and some sort of treatment.

I will be president-elect of the ISH until October 2006, and I will become president at the end of the ISH meeting in Fukuoka, Japan and remain in office until the end of the 2008 Joint ISH-ESH meeting in Berlin. The planning for the Fukuoka meeting is going very well, and I’m sure that we will have a huge attendance and a lot of interesting science to discuss. There will be many Satellite Symposia held in several parts of Asia. Fukuoka is a lovely place in an interesting part of the world. I do encourage Europeans to come, because this is a very interesting part of the world, which, unbelievably, many people haven’t actually seen. Japan is not just Tokyo; a lot of people from Europe go to Tokyo and Osaka and that is it, but there is so much to see. Ad if you are interested in culture, Fukuoka is a gold mine.

 
DAILY ARTICLES
Reflections from Prof. Anthony Heagerty,
President of the European Society of Hypertension

Message from Prof. Giuseppe Mancia,
Chairperson of the 15th European Meeting on Hypertension, held June 17-21, 2005 inMilan, Italy

Comments by Prof. Michael Alderman,
President of the International Society of Hypertension
Comments by Prof. Lars Lindholm,
President-elect of the International Society of Hypertension
 
Legal
The materials presented here were prepared by independent authors under the editorial supervision of ESHonline, and do not represent a publication of the European Society of Hypertension. These materials and the related activity are not sanctioned by the European Society of Hypertension and do not constitute an official part of that conference. These materials may discuss uses and dosages for therapeutic products that have not been approved by the nationals and internationals Laws. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © ESHonline.org.